Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CRH PLC Board/Management Information 2013

Feb 26, 2013

1980_rns_2013-02-26_6b43a6eb-6e2f-436b-976e-dd6a0f327506.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6359Y

CRH PLC

26 February 2013

N      E      W      S                R      E      L      E      A      S      E

26 February 2013

CRH plc ANNOUNCES GROUP CHIEF EXECUTIVE'S INTENTION TO RETIRE

AT THE END OF 2013

CRH plc, the international building materials group, announces that Myles Lee, Group Chief Executive, has confirmed to the Board his intention to retire from CRH at the end of 2013 having reached the age of 60, and following completion of a five year term as Chief Executive and ten years as an Executive Director.    Myles joined CRH in 1982, joining the Board in November 2003 as Finance Director, later becoming Chief Executive in January 2009. 

Commenting on this, the Chairman Nicky Hartery said, "Myles has contributed very significantly over an extended period to the development and progress of CRH and continues to do so.  By advising the Board of his decision well in advance of retirement, Myles has, in line with long-established CRH practice, facilitated the planning and management of his succession in an ordered and timely fashion.   The Board has appointed a Committee, chaired by myself, to conduct the search for a successor to Myles."

CRH plc, Belgard Castle, Clondalkin, Dublin 22, Ireland TELEPHONE +353 1 404 1000   FAX +353 1 404 1007

E-MAIL: [email protected]    WEBSITE: www.crh.com    Registered Office, 42 Fitzwilliam Square, Dublin 2, Ireland

This information is provided by RNS

The company news service from the London Stock Exchange

END

FURLLFSTFLIEFIV